BackgroundCheck.run
Search For

Brian E Pfister, 52108 16Th St, Wilmette, IL 60091

Brian Pfister Phones & Addresses

108 16Th St, Wilmette, IL 60091    847-2565772   

Evanston, IL   

San Diego, CA   

Elgin, IL   

Chicago, IL   

Pine, CO   

Naperville, IL   

108 16Th St, Wilmette, IL 60091   

Work

Position: Food Preparation and Serving Related Occupations

Education

Degree: High school graduate or higher

Mentions for Brian E Pfister

Brian Pfister resumes & CV records

Resumes

Brian Pfister Photo 45

Senior Vice President

Location:
2200 Pennsylvania Ave northwest, Washington, DC 20037
Industry:
Government Relations
Work:
Tunnell Government Services since Oct 2010
Principal Consultant - Strategic Portfolio Manager, Regenerative Medicine Program
Articular Engineering, LLC Jul 2009 - Oct 2010
CEO
Northland Laboratories Mar 2007 - Oct 2010
Technical Director
Articular Engineering Aug 2000 - Jul 2009
General Manager
Education:
University of Notre Dame - Mendoza College of Business 2008 - 2009
MBA
Rush University 1994 - 1999
Ph.D., Biochemistry
Beloit College 1990 - 1994
BS, Chemistry
Skills:
Cell Culture, Biochemistry, Biotechnology, Life Sciences, Regenerative Medicine, Medical Devices, Tissue Engineering, Clinical Research, Strategy, Laboratory, Assay Development, Biologics, Commercialization, Fda, Technology Transfer, Molecular Biology, Orthopedic, Lifesciences, Immunology, Chemistry
Interests:
Adventure Racing
Endurance Events
Brian Pfister Photo 46

Brian Pfister

Publications & IP owners

Us Patents

Tissue Engineered Osteochondral Implant

US Patent:
7931687, Apr 26, 2011
Filed:
May 12, 2003
Appl. No.:
10/435883
Inventors:
Koichi Masuda - Wilmette IL, US
Michael J. Hejna - Riverside IL, US
Brian E. Pfister - Wilmette IL, US
Assignee:
Articular Engineering, LLC - Northbrook IL
Rush University Medical Center - Chicago IL
International Classification:
A61F 2/02
US Classification:
623 1111, 623901, 435382, 435395, 424 937, 424422, 424423
Abstract:
Compositions, methods of production and use, and kits for an osteochondral graft involving both articular cartilage and underlying bone are provided.

Tissue Engineered Cartilage For Drug Discovery

US Patent:
2003013, Jul 24, 2003
Filed:
Jan 22, 2002
Appl. No.:
10/054710
Inventors:
Koichi Masuda - Wilmette IL, US
Eugene Thonar - Lockport IL, US
Brian Pfister - Wilmette IL, US
Michael Hejna - Riverside IL, US
International Classification:
C12Q001/22
C12Q001/18
US Classification:
435/031000, 435/032000
Abstract:
A culture system and method for determining the effect of a test agent on the development, homeostasis or degradation of engineered cartilage tissue. The engineered cartilage tissue is obtained by isolating chondrogenic cells and culturing them to obtain chondrocytes in a cell-associated matrix. The chondrocytes and cell associated matrix are then cultured on a semipermeable membrane to provide the engineered cartilage tissue. The engineered tissue, or one of its precursors, can be contacted with the test agent to determine what effect, if any, the test agent has on engineered cartilage.

Antibodies, Assays And Kits To Quantitate Cartilage Destruction

US Patent:
2007009, May 3, 2007
Filed:
Nov 1, 2006
Appl. No.:
11/591307
Inventors:
John Sandy - Tampa FL, US
Koichi Masuda - Wilmette IL, US
Brian Pfister - Wilmette IL, US
International Classification:
G01N 33/567
C12P 21/04
C07K 16/40
US Classification:
435007200, 530388260, 435070210
Abstract:
Antibody compositions specific for peptides released during arthritic cartilage destruction are provided as reagents for assay of progression of arthritic processes for antibodies, and as diagnostic and prognostic agents. Also provided are methods and kits for this assay.

Methods And Compositions For Remediation Of Disc Herniation By Modifying Structure

US Patent:
2007025, Nov 8, 2007
Filed:
May 1, 2007
Appl. No.:
11/799393
Inventors:
Brian E. Pfister - Wilmette IL, US
International Classification:
A61K 31/785
A61K 31/715
A61K 31/718
A61K 31/722
A61K 38/47
US Classification:
424 7827, 424 9461, 514 55, 514 54, 514 59
Abstract:
A therapeutic method and compositions are provided that involve injection of a cation solution into extracellular matrix of a tissue. In the preferred embodiment, a percutaneous (performed through the skin) injection of a polylysine solution into the nucleus of a herniated disc is provided, to reduce intradiscal pressure.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.